ColonRectalGastroenterologyHematology & OncologyInternal MedicinePathologyGeriatricsColon CancerCancerRectal CancerGeneral HealthScreeningSenior HealthSeniors
HealthDay operates under the strictest editorial standards. Our syndicated news content is completely independent of any financial interests, is based solely on industry-respected sources and the latest scientific research, and is carefully fact-checked by a team of industry experts to ensure accuracy.
- All articles are edited and checked for factual accuracy by our Editorial Team prior to being published.
- Unless otherwise noted, all articles focusing on new research are based on studies published in peer-reviewed journals or issued from independent and respected medical associations, academic groups and governmental organizations.
- Each article includes a link or reference to the original source.
- Any known potential conflicts of interest associated with a study or source are made clear to the reader.
Please see our Editorial and Fact-Checking Policy for more detail.Editorial and Fact-Checking Policy
HealthDay Editorial Commitment
HeathDay is committed to maintaining the highest possible levels of impartial editorial standards in the content that we present on our website. All of our articles are chosen independent of any financial interests. Editors and writers make all efforts to clarify any financial ties behind the studies on which we report.
TUESDAY, June 11, 2019 (HealthDay News) -- The incremental diagnostic yield of Lynch syndrome (LS) screening decreases substantially after age 70 to 75 years, according to a study published online June 11 in the Annals of Internal Medicine.
Dan Li, M.D., from Kaiser Permanente Northern California in Santa Clara, and colleagues compared the performance of age-restricted and universal LS screening using reflex mismatch repair (MMR) immunohistochemistry (IHC) of colorectal cancer (CRC) tumors in a retrospective cohort study. Data were included for 3,891 persons with newly diagnosed CRC who underwent LS screening between 2011 and 2016.
The researchers identified 63 LS cases (diagnostic yield, 1.62 percent) with universal screening, with five cases and one case (7.9 and 1.6 percent) detected after age 70 and 80 years, respectively. Using all patients with CRC with universal screening as the denominator, 58, 60, and 62 LS cases were identified in those with CRC diagnosed at or before age 70, 75, and 80 years, respectively (diagnostic yield, 1.49, 1.54, and 1.59 percent, respectively). Three of 63 LS cases were missed using 75 years as the upper age limit for screening, while 1,053 (27.1 percent) fewer cases required tumor MMR IHC. One LS case was missed and 668 (17.2 percent) fewer cases required tumor MMR IHC using 80 as the upper age limit.
"Age was a key determinant of LS screening performance using reflex MMR IHC on CRC tumors in a large community-based setting," the authors write.
One author disclosed financial ties to the biopharmaceutical industry.
This story may be outdated. We suggest some alternatives.
The content contained in this article is over two years old. As such our recommendation is that you reference the articles below for the latest updates on this topic. This article has been left on our site as a matter of historic record. Please contact us at email@example.com with any questions.
Updated on May 27, 2022
Read this Next
Other Trending Articles